SCHEDULE: Dimensional Fund Advisors Reports 4.9% Stake in Elanco

Dimensional Fund Advisors LP has disclosed a beneficial ownership of 4.9% of Elanco Animal Health Inc.'s common stock as of March 31, 2026.

Summary

• Dimensional Fund Advisors LP (DFA) has filed a Schedule 13G, indicating its beneficial ownership of Elanco Animal Health Inc. common stock.
• As of March 31, 2026, DFA beneficially owns 24,527,135 shares, representing 4.9% of the class of securities.
• DFA holds sole voting power over 24,146,632 shares and sole dispositive power over 24,527,135 shares.
• The filing clarifies that DFA acts as an investment adviser to various investment companies and commingled funds that own these shares.
• DFA disclaims beneficial ownership of these securities, stating they are owned by the Funds it advises.
• The securities were acquired and are held in the ordinary course of business and not for the purpose of influencing control of Elanco.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing. It's a routine disclosure of institutional ownership, indicating a significant investment but not providing new operational or financial performance data for Elanco Animal Health Inc.

Positives

• Dimensional Fund Advisors LP, a significant investment manager, holds a substantial stake in Elanco Animal Health Inc., suggesting confidence in the company's value.
• The filing indicates that the shares are held in the ordinary course of business, implying a standard investment strategy rather than a hostile takeover attempt.

Negatives

• The filing does not contain any negative financial results or operational challenges for Elanco Animal Health Inc.

Risks

• While not explicitly stated as risks in this filing, a significant ownership stake by an investment advisor could lead to potential influence on corporate strategy or governance decisions, which may or may not align with other shareholders' interests.

Future Outlook

This filing is a disclosure of ownership and does not contain forward-looking statements or guidance from Elanco Animal Health Inc.

Management Comments

• "Dimensional Fund Advisors LP, an investment adviser registered under Section 203 of the Investment Advisors Act of 1940, furnishes investment advice to four investment companies registered under the Investment Company Act of 1940, and serves as investment manager or sub-adviser to certain other commingled funds, group trusts and separate accounts... Dimensional disclaims beneficial ownership of such securities."
• "In addition, the filing of this Schedule 13G shall not be construed as an admission that the reporting person or any of its affiliates is the beneficial owner of any securities covered by this Schedule 13G for any other purposes than Section 13(d) of the Securities Exchange Act of 1934."
• "By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11."

Industry Context

StockSavvy.ai notes that significant institutional ownership, as reported by Dimensional Fund Advisors LP, is common in the animal health sector, reflecting investor interest in stable, growing markets. Elanco Animal Health Inc. operates in a competitive landscape with other major players like Zoetis and Boehringer Ingelheim Animal Health.

Stakeholder Impact

• Shareholders: The disclosure confirms a significant investment by a major asset manager, which can be seen as a positive signal of confidence in the company's long-term prospects. However, it also means that a substantial portion of shares is managed by one entity, potentially influencing voting power.
• Management: The filing does not directly impact Elanco's management but highlights the presence of a large institutional investor whose interests management must consider.
• Creditors: No direct impact on creditors is indicated by this filing.

Next Steps

• Continue to monitor future filings from Dimensional Fund Advisors LP regarding their stake in Elanco Animal Health Inc.
• Observe any potential changes in Elanco's strategic direction that might be influenced by significant institutional investors.

Key Dates

Keywords

Elanco Animal Health Inc, Dimensional Fund Advisors LP, Schedule 13G, Beneficial Ownership, Investment Adviser, Common Stock, SEC Filing, Securities Exchange Act